8-K
filed March 18, 2025, 7:59 PM ET
ticker WHWK
CIK 0001422142
other material
confidence high
sentiment positive
materiality 0.80
Aadi Bioscience relaunches as Whitehawk Therapeutics; reports FY2024 net loss $63.7M, $100M PIPE closed
Whitehawk Therapeutics, Inc.
- Name changed to Whitehawk Therapeutics; stock begins trading under 'WHWK' on Nasdaq effective March 19, 2025.
- Closed $100M PIPE financing; pending divestiture of FYARRO business to Kaken Pharmaceuticals.
- Cash position $47.2M at Dec 31, 2024; expected $170-180M after transactions, funding operations into 2028.
- FY2024 total revenue $26.0M from FYARRO; net loss $63.7M vs $65.8M in 2023.
- ADC portfolio: three assets targeting PTK7, MUC16, SEZ6; goal to bring all to IND within 15 months.
Key facts
Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.99
Whitehawk Therapeutics, Inc.: Company amended its certificate of incorporation to change its name from Aadi Bioscience, Inc. to Whitehawk Therapeutics, Inc (effective 2025-03-18).
- Change
- charter amendment
- Effective
- 2025-03-18
Exact text from the filing
The board of directors (the “ Board ”) of the Company approved an amendment to the Company’s amended and restated certificate of incorporation (the “ Charter ”), to change the Company’s name to Whitehawk Therapeutics, Inc. (the “ Name Change ”). On March 18, 2025, the Company filed a certificate of amendment (the “ Name Change Charter Amendment ”) to the Charter with the Secretary of State of the State of Delaware, which effected the Name Change.
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.99
Whitehawk Therapeutics, Inc.: Board approved an amendment and restatement of the bylaws solely to reflect the name change to Whitehawk Therapeutics, Inc (effective 2025-03-18).
- Change
- bylaw amendment
- Effective
- 2025-03-18
Exact text from the filing
Additionally, the Board approved an amendment and restatement of the Company’s bylaws solely to reflect the Name Change (the “ Amended and Restated Bylaws ”). The Amended and Restated Bylaws became effective upon the effectiveness of the Name Change Charter Amendment.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.